BioPortfolio Blog about Biotechnology, Pharmaceutical and Healthcare

02:30 EST 21st February 2017 | BioPortfolio

Updates and info from the contributors bringing you

Showing News Articles 1–5 of 10,000+

Tuesday 21st February 2017

Global Epilepsy Partnering 2010 to 2017 [Updated: 01022017] Prices from USD $1495

The Global Epilepsy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. Trends in partnering deals Top deals by value Deals listed by company AZ, industry sector, stage of development, technology typeThe report provides understanding and access to the partnering deals and ag...

Monday 20th February 2017

Curis Inc CRIS Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250

SummaryCuris Inc Curis is a biotechnology company focused at developing and commercialization of novel drug candidates for treating human cancers. The company's lead product, Erivedge is an FDA approved medicine for the treatment of advanced basal cell carcinoma and is being commercialized and developed by Genentech under a collaboration agreement. The company's lead drug candidate is CUDC907, an ...

Commercial Flight Management Systems Market North America by Cockpit Architecture VIA, WBA, NBA, and RTA, Hardware FMC, CDU, and VDU Forecast and Analysis to 2019 Prices from USD $2650

The flight management systems market is very dynamic and new technologies have been evolved over the years to reduce the efforts of pilot. FMS on board ensures that the aircraft is flying on the most efficient route and aids to low fuel consumption, flight time, and crew workload. The U.S. dominates the North American market for flight management systems and is expected to remain a major market i...

Quorum Health Corp QHC Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300

SummaryQuorum Health Corp QHC is an operator of general acute care hospitals that provides outpatient services. The company owns and leases hospitals and outpatient centers across the US. Its hospitals provides general hospital healthcare services including general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic services, psychiat...

NeuroVive Pharmaceutical AB NVP Financial and Strategic SWOT Analysis Review [Updated: 13012017] Prices from USD $300

SummaryNeuroVive Pharmaceutical AB NeuroVive, formerly Neuro Pharma is a pharmaceutical company that research and develops pharmaceuticals to protect mitochondria from post acute traumatic injury. The company's drug development technology platform comprises cyclosporineA for the treatment of acute traumatic conditions. It conducts clinical trials of ciclomulsion and neuroSTAT in humans. NeuroVive ...

Quick Search